Organogenesis Holdings Inc (ORGO) — Cash Flow Reinvestment Rate
Organogenesis Holdings Inc (ORGO) has a Cash Flow Reinvestment Rate of 1.45x as of September 2025, reinvesting $4.47 Million (capex $2.23 Million plus investments $-2.23 Million) from operating cash flow of $3.08 Million. See Organogenesis Holdings Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Organogenesis Holdings Inc Cash Flow Reinvestment Rate (2020–2024)
Historical reinvestment intensity for Organogenesis Holdings Inc across 5 annual periods. For the full cash flow conversion analysis, see Organogenesis Holdings Inc cash conversion from operations.
Annual Cash Flow Reinvestment Rate for Organogenesis Holdings Inc (2020–2024)
Year-by-year capital reinvestment analysis for Organogenesis Holdings Inc. See Organogenesis Holdings Inc (ORGO) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.41x | $20.06 Million | $14.21 Million | $10.03 Million | ▼ -22.1% |
| 2023 | 1.81x | $56.06 Million | $30.92 Million | $24.36 Million | ▼ -33.5% |
| 2022 | 2.73x | $67.80 Million | $24.86 Million | $33.90 Million | ▲ +170.7% |
| 2021 | 1.01x | $62.44 Million | $61.98 Million | $31.22 Million | ▼ -87.0% |
| 2020 | 7.78x | $42.51 Million | $5.47 Million | $17.68 Million | — |